PF-04217903doxorubicinLY2090314corticosteroidsTLR agonistsMet-driven tumors
… for immunotherapy combinations. For example, the Met inhibitor PF-04217903 potently induced CXCL9-10 and IL-12 expression by hepatocytes, …
1articles mentioning drugs
1drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: LY2090314 ×
LY2090314
This drug is selected. Its supporting articles are shown below.